Tab ciplox dose
| Indication | Dose | Frequency | Duration |
|---|---|---|---|
| General mild-moderate infections | 250-500 mg | Q12h (BD) | Per clinical judgment |
| Severe/complicated infections | 750 mg | Q12h (BD) | Per clinical judgment |
| Uncomplicated UTI/cystitis | 250 mg | Q12h | 3 days |
| Complicated UTI / Pyelonephritis | 500 mg | Q12h | 7-14 days |
| Respiratory tract infections | 500-750 mg | Q12h | 7-14 days |
| Skin & soft tissue | 500-750 mg | Q12h | 7-14 days |
| Typhoid / enteric fever | 500 mg | Q12h | 7-10 days |
| GI infections / traveler's diarrhea | 500 mg | Q12h | 5-7 days |
| Chancroid (STI) | 500 mg | Q12h | 3 days |
| Gonorrhea (if susceptible) | 500 mg | Single dose | - |
| Anthrax (post-exposure prophylaxis) | 500 mg | Q12h | 60 days |
| Anthrax (inhalational/systemic) | 500 mg | Q12h PO | 60 days (IV + PO combined) |
| Indication | Dose | Frequency |
|---|---|---|
| Uncomplicated UTI/cystitis | 500 mg | Once daily |
| Complicated UTI / uncomplicated pyelonephritis | 1000 mg | Once daily |
| Indication | Dose |
|---|---|
| Mild/moderate infection | 20 mg/kg/24h divided Q12h (max 1 g/day) |
| Severe infection | 30-40 mg/kg/24h divided Q12h (max 1.5 g/day) |
| Complicated UTI/pyelonephritis | 20-40 mg/kg/24h divided Q12h (max 1.5 g/day) |
| Cystic fibrosis | 40 mg/kg/24h divided Q12h (max 2 g/day) |
| Anthrax (post-exposure) | 20-30 mg/kg/24h divided Q12h x 60 days (max 1 g/day) |